Tryptophanyl-tRNA synthetase 1 (WARS1)

Tryptophanyl-tRNA synthetase 1 is an essential cytoplasmic enzyme that catalyzes the attachment of tryptophan to its cognate tRNA, a critical step in protein synthesis[2][3]. Beyond this canonical role, WARS1 also acts as an endogenous ligand for Toll-like receptors TLR2 and TLR4, triggering innate immune responses in monocytes and macrophages, including robust induction of cytokines and chemokines through MyD88, TRIF, and TREM-1 signaling pathways[1]. Isoforms of WARS1 may have additional roles, such as anti-angiogenic activity. Mutations or dysregulation of WARS1 are associated with neurodevelopmental disorders, inflammatory diseases, and certain cancers, highlighting its broader significance beyond protein translation[2][4]. No drugs directly inhibit WARS1, though inhibitors of downstream effectors are used for research. Marker proteins such as interferon-induced protein 53 and soluble TREM-1 are elevated in response to WARS1-mediated immune activation, which can also serve as disease or therapeutic biomarkers[1][2].

Other names

Tryptophan--tRNA ligase, cytoplasmicT1-TrpRST2-TrpRSIFI53WARSWRSIFP53TrpRShWRSInterferon-induced protein 53Tryptophanyl-tRNA synthetasetryptophan tRNA ligase 1, cytoplasmicGAMMA-2HMN9HMND9NEDMSBAepididymis secretory sperm binding protein

Inhibition of downstream Syk kinase (using Syk inhibitors such as R406) can block WARS1-triggered TREM-1 signaling and amplify innate immune responses[1].